Therapeutic potential of tricarboxylic acid cycle metabolite itaconate in cardiovascular diseases

[1]  Y. Liao,et al.  Itaconate prevents abdominal aortic aneurysm formation through inhibiting inflammation via activation of Nrf2 , 2020, EBioMedicine.

[2]  D. Pagliarini,et al.  Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-γ stimulation , 2019, Nature Metabolism.

[3]  M. Oosting,et al.  The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity. , 2019, Cell metabolism.

[4]  Edward T Chouchani,et al.  Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1 , 2018, Nature.

[5]  Maxim N. Artyomov,et al.  Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis , 2018, Nature.

[6]  Akhileshwar Namani,et al.  Nrf2 signaling pathway: Pivotal roles in inflammation. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[7]  R. Xavier,et al.  Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages , 2016, Cell.

[8]  Maxim N. Artyomov,et al.  Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.

[9]  K. Nakayama,et al.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.

[10]  K. Pfeffer,et al.  The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.